Mira Pharmaceuticals (MIRA) Net Income towards Common Stockholders (2022 - 2025)
Mira Pharmaceuticals (MIRA) reported Net Income towards Common Stockholders of -$5.98 million for the quarter ended Dec 31, 2025, compared with -$2.4 million a year earlier.
Powered by 
Analysis
Mira Pharmaceuticals (MIRA) Net Income towards Common Stockholders (2022 - 2025) Analysis & Trends
For the year ended Dec 31, 2025, Mira Pharmaceuticals posted Net Income towards Common Stockholders of -$32 million.
- By year, Net Income towards Common Stockholders came in at -$7.85 million in the year ended Dec 31, 2024, -$11.98 million in the year ended Dec 31, 2023 and -$7.06 million in the year ended Dec 31, 2022.
- Five-year quarterly Net Income towards Common Stockholders spans a low of -$22.69 million in the quarter ended Sep 30, 2025 and a high of -$1.27 million in the quarter ended Jun 30, 2023.
- Per Business Quant data, the three quarters before the quarter ended Dec 31, 2025 came in at -$22.69 million (quarter ended Sep 30, 2025), -$1.54 million (quarter ended Jun 30, 2025) and -$1.78 million (quarter ended Mar 31, 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,199.50 Bn | 1,168.08 Bn | 19.71 Bn | 7.10 Bn |
| 2 | Johnson & Johnson | 635.17 Bn | 555.03 Bn | 17.30 Bn | 210.00 Mn |
| 3 | AbbVie | 504.69 Bn | 477.85 Bn | 12.70 Bn | 3.61 Bn |
| 4 | Merck | 358.43 Bn | 312.86 Bn | 12.21 Bn | -1.34 Bn |
| 5 | Novartis Ag | 288.36 Bn | 252.75 Bn | 11.24 Bn | 3.26 Bn |
| 6 | Astrazeneca | 265.78 Bn | 239.54 Bn | 12.86 Bn | 2.51 Bn |
| 7 | Amgen | 237.46 Bn | 192.86 Bn | 7.24 Bn | 2.38 Bn |
| 8 | Gilead Sciences | 193.65 Bn | 167.76 Bn | 6.22 Bn | -10.50 Bn |
| 9 | Pfizer | 171.05 Bn | 118.00 Bn | 10.94 Bn | -248.00 Mn |
| 10 | Mira Pharmaceuticals | 14.69 Mn | -5.81 Mn | - | -5.98 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | -5.98 Mn |
| Sep 30, 2025 | -22.69 Mn |
| Jun 30, 2025 | -1.54 Mn |
| Mar 31, 2025 | -1.78 Mn |
| Dec 31, 2024 | -2.40 Mn |
| Sep 30, 2024 | -2.04 Mn |
| Jun 30, 2024 | -1.69 Mn |
| Mar 31, 2024 | -1.72 Mn |
| Dec 31, 2023 | -5.79 Mn |
| Sep 30, 2023 | -3.59 Mn |
| Jun 30, 2023 | -1.27 Mn |
| Mar 31, 2023 | -1.34 Mn |
| Dec 31, 2022 | -1.35 Mn |
| Sep 30, 2022 | -1.81 Mn |
| Jun 30, 2022 | -2.42 Mn |
API Access
Mira Pharmaceuticals Net Income towards Common Stockholders API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-income-towards-common-stockholders&ticker=MIRA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-income-towards-common-stockholders", "ticker": "MIRA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-income-towards-common-stockholders&ticker=MIRA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();